Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway. (Q40720889)
Jump to navigation
Jump to search
scientific article published on July 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway. |
scientific article published on July 2002 |
Statements
Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway (English)
Alan T Remaley
Isaac Yi Kim
Do Hwan Seong
Byung-Chul Kim
Dug Keun Lee
Fredrick Leach
Ronald A Morton